요실금약 urinary incontinence medications, T885

요실금약 urinary incontinence medications 

 

넓은 의미의  요로 진경제 鎭痙劑-경련억제제, Urinary AntiSpasmodics, 안에

요실금 약이 포함된다. 그러나 모든 요로 경련억제제가 요실금 약은 아니다. 

 

요로 경련 억제제 AntiSpasmodics, 엔타이(엔티)스파즈마(머)딕,

발음; æntaɪspæzˈmɑdɪk; æntispæzˈmɑdɪk,

-------------

요실금 약, 부작용, 

 

21 Medications for Urinary Incontinence,

 

Rx; prescription,   OTC; over-the-counter, 처방없이 살수 있는 약들,

CSA; Controlled Substances Act, 규제 물질 법,

Activity 는 사용 활동 대중성 도표 초록줄,

Drug.com

https://www.drugs.com/condition/urinary-incontinence.html?sort=drug&order=asc

List of 21 Urinary Incontinence Medications Compared

 

-------------

67 medications found for ‘urinary incontinence’

Webmd

https://www.webmd.com/drugs/2/condition-3254/urinary-incontinence

Compare Current Urinary-Incontinence Drugs and Medications with Ratings & Reviews

 

 

(ER) Extended Release, 효력이 더 오래 지속되는약물;

an extended-release medication is usually labeled with “ER” or “XR” at the end of its name. Medications that have ER forms are designed to make them last longer in your body.

 

(SR) Sustained Release, 천천히 녹아서 오랜 시간 지속되는 약물; 

Sustained-release medications are usually labeled with “SR” at the end of their name. These medications prolong the medication’s release from a tablet or capsule so that you’ll get the medication’s benefits over a longer period of time. This means that you may need to take fewer doses throughout the day.

 

(CR) Controlled Release;

특정 기간 동안 신체의 약물 수준을 일정하게 유지하기 위해 특정 속도로 활성 성분을 방출,

a controlled-release medication is usually labeled with “CR” at the end of its name. CR medications release the active ingredient(s) at a specific rate to keep constant medication levels in your body for a specific time period. This allows for more precise control of medication levels after taking it and fewer doses needed throughout the day.

 

(DR) Delayed Release ; 소장등 특별한 장기에 가서 작용하도록 늦게 지연되는 약물,

Delayed-release (DR) medications are medications that are designed to release the active ingredient(s) later after taking it, which can help control where it’s released in the body (e.g., small intestines). This is usually done to prevent the medication from being broken down too early or lessen potential side effects.

Some DR medications cause the active ingredient(s) to be released in the large intestine (the colon) in order to reach the area being treated.

 

EC, Enteric-Coated or “safety-coated” ;

^^enteric-coated ; 장용제피(腸溶劑皮)의. 정제 또는 캡슐제가 장에 도달하기 이전에는 그의 내용이 방출이나 흡수되지 못하게 하기 위하여 겉을 싼 특수한 외피(外皮)를 일컫는 용어.

위장에서는 녹지 (분해되지) 않고 지연되도록 특별한 피막이 입혀진 약물,

 

Enteric-coated (EC or “safety-coated”) medications are also considered to be a DR dosage form. They have a special film coating that stops them from being broken down in the stomach. This prevents the medication from being released until it reaches the small intestine, which may help lessen certain side effects, like an upset stomach.